EUFEP-Congress 2011

09:00 - 09:30

Opening: Welcome

09:30 – 11:00

Plenum I: The burden of disease and international strategies to fight cancer

Moderation: Prof. Dr. Gerald Gartlehner, MPH

1. Dr. Rolando Herrero, MD, PhD, Prevention and Implementation Group Early Detection and Prevention Section International Agency for Research on Cancer, World Health Organisation, Lyon, Frankreich
„Cancer control policies, plans and programmes: WHO perspective"

2. Dr.ⁱⁿ Marjetka Jelenc, MD, PhD, National Institute of Public Health, Ljubljana, Slowenien
"European Partnership for Action against Cancer"

3. Dr.ⁱⁿ Michaela Girgenrath, Bundesministerium für Gesundheit, Deutschland
„The German National Cancer Plan with particular reference to early detection and a more patient-centered approach”

Forum: Discussion with all participants of the plenum and audience

11:00 – 11:30

Break

11:30 – 12:45

Session 1a: Topic: Konfrontation – Prostatakarzinom Screening

Moderation: Prim Dr. Johannes Püspök

1. Primar Dr. Wolfgang Loidl, Barmherzige Schwestern, Linz, Austria
„Prevention of prostate cancer, early diagnosis, PSA hysteria: Men between ignorance and anxiety“

2. PD Dr. Stefan Lange, IQWIG, Köln, Germany
„Benefit and harm of PSA-Screening“

Session 1b: Praktische Herausforderungen bei der Erstellung evidenzbasierter Leitlinien

1. Mag.^a Karin Eger, Wiener Gebietskrankenkasse, Abteilung Gesundheitspolitik und Prävention, Austria
"Early detection aof breast cancer - The evidence versus the reality”

2. Prof.ⁱⁿ Dr.ⁱⁿ Beate Wimmer Puchinger, Wiener Frauengesundheitsbeauftragte, Austria
„Early detection of breast cancer - the informed woman?!“

12:45 – 14:15

Lunch

14:15 – 15:30

Session 2a: Konfrontation – Mammographiescreening

Moderation: Martin Sprenger, MD, MPH

1. Karsten Juhl Jørgensen, The Nordic Cochrane Centre, Kopenhagen, Dänemark
„Does screening for breast cancer reduce mortality from the disease?”

2. Prof. Dr. Wolfgang Buchberger, TILAK, Innsbruck, Österreich
„Results of the Tirolean Mammography Program“

Session 2b: Clinical Prevention: Bewegung und Krebsprävention

Moderation: Prof. Dr. Norbert Bachl

1. DIⁱⁿ Dr.ⁱⁿ Barbara Wessner, PhD, Center for Sports, Sciences and University Sports, University of Vienna, Austria
„Exercise, oxidative stress and cancer incidence: is there a need for antioxidants?“

2. Univ. Doz. Dr. Günther Neumayr, Praxis Univ. Doz. Dr. Neumayr, Innere Medizin/Kardiologie/ Sportmedizin, Lienz, Austria
„The positive influence of physical actibity on carcinogenesis“

15:30 – 16:00

Break

16:00 – 17:15

Session 3a: Dickdarmkrebsscreening

Moderation: Dr.ⁱⁿ Kylie Thaler, MPH

1. Prof.ⁱⁿ Nea Malila, PhD, University of Tampere, Tampere School of Public Health, Finnland
„Results of the Finnish Colon Cancer Screening Program”

2. Prof. Dr. Hermann Brenner, Deutsches Krebsforschungszentrum, Heidelberg, Germany
„Protection from colorectal neoplasms after colonoscopy: results of epidemiological studies from Germany“

Session 3b: Evaluation von Krebspräventionsprogrammen

Moderation: Mag. Ludwig Grillich

1. Geoffrey Fong, PhD, University of Wateloo, Canada
"The International Tobacco Control Policy Evaluation Project"

2. Prof. François Alla, MD, PhD, Public health school, Universität Nancy, France
„Evaluation of the first French Cancer Plan – Lessons to learn for prevention”

15:30 – 18:00

Workshop for Journalists

ab 19:00                           

Evening Event

09:15 – 10:45 

Plenum II: Cancer Screening: Sense and Persuasion?

Moderation: Stefan Löffler

1. Prof. Dr. James Dillard, Pennsylvania State University, USA
“The Persuasive Influence of Emotion in Cancer Prevention and Detection”

2. Dr. Eldon Spackman, PhD, Centre for Health Economics, University of York, UK
“Health economics of preventative medicine: Is an ounce of screening worth a pound (1.15 EUR)?"

3. Sue Ziebland, BA (Hons) MSc, University Reader in Qualitativer Health Research, University of Oxford, UK
“Decisions and reflections on cancer screening: Patients perspectives from www.healthtalkonline.org“

Forum: Discussion with all participants of the plenum and audience

10:45 – 11:15 

Break

11:15 – 12:30 

Session 4a: Decision Aids

Moderation: Univ.-Prof.ⁱⁿ Dr.ⁱⁿ Èva Ràsky

1. Dr.ⁱⁿ Brigitte Piso, MPH, Ludwig Boltzmann Institut für Health Technology Assessment
„Development of an evidence-based decision-aid on HPV vaccination“

2. Dr.ⁱⁿ phil. Britta Lang, MSc, German Cochrane Centre, senior researcher
"Decisioin Aids and Medicine 2.0 - knowledge transfer for the patient of tomorrow"

Session 4b: Gesundheitsökonomie

Moderation: Mag. Klaus Schuster, MSc, MBA

1. Dr. Lesley Rushton, School of Public Health, London, Department of Epidemiology and Biostatistics, UK
"Toward risk reduction: predicting the future burden of occupational cancer"

2. PD Dr. Matthias Schwenkglenks, MPH, Institute of Parmaceutical Medicine, University of Basel und Institute of Social und Preventive Medicine, University of Zürich, Switzerland
“Screening for prostate cancer-health economic considerations“

12:30 – 14:15

Lunch Break

13:15 – 14:15

Presentation of Posters (SL, MS)

Session 5: Vermeidbare Risikofaktoren

Moderation: Dr.ⁱⁿ Anna Glechner

1. Dr.ⁱⁿ med. Kathryn Hoffmann, MD, MPH, Medical University of Vienna, Austria
„Smoking as a single greatest avoidable risk for cancer - The necessity for Austia translate Evidence into Action”

2. OA Assoz.-Prof. Priv-Doz. DI rer nat tech. Dr. med. univ. Hans-Peter Hutter, Institut für Umwelthygiene, Universität Wien, Wien, Austria
"Cancer and environmental possibilities of behavior-oriented prevention and condition-oriented prevention: current trends"

Session 5b: Konsumenteninformation

Moderation: Ingeborg Beunders, MAS, MBA

1. Dr.ⁱⁿ Anke Steckelberg, University of Hamburg, Germany
„Evidence–based patient information - man`s emergence from his not self-imposed immaturity“

2. Hazel Thornton, Hon. DSc, Honorary Visiting Fellow, Universität Leicester, UK
„Informed Decision Making – what citizens need to know”

15:30 – 16:00

Kaffeepause

16:00 – 17:15

Session 6: Multiorgan Screening

Moderation: Dr. Franz Piribauer, MPH

1. Priv.-Doz. Dr. med. Dipl.-Phys. Wolfgang Luboldt, MD, MSc, Multiorgan Screening Foundation, Munch, Germany
„Multiorgan Screening with PET/CT: All-in-one?“

2. Dr. Klaus Koch, IQWIG, Cologne, Germany
„Multiorgan Screening: More benefit than harm?“

Session 6b: Krebs und Ernährung

Moderation: Mag.^a Christina Kien

1. Prof. Dr. Rudolf Kaaks, German Cancer Research Center, Heidelberg, Germany
„Diet and Cancer - results from the EPIC study“

2. Dipl.-Oecotroph.in Nadine Wagner, Institut für Ernährungspsychologie, Universität Göttlingen, Germany
„Psychological regulation of eating habits“

17:15                      

Farewell - End of Congress